nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-A82BD6FA·Framework v5.8·Pipeline v0.4·Evaluated 17 Aug 2026·OECD: 3.2 Clinical medicine·Subfield: Biological Psychiatry·Basis: Full text·Type: Systematic review

The serotonin theory of depression: a systematic umbrella review of the evidence.

Moncrieff et al.Moncrieff, Cooper, Stockmann et al.·2022·10.1038/s41380-022-01661-0 ↗

Primary claim

The main areas of serotonin research provide no consistent evidence of there being an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations.

Supported · certainty-graded findings broadly converge, but several non-genetic domains remain small, confounded, or very low certainty
In brief

A consequential umbrella review undermines the low-serotonin account of depression, but the underlying evidence is heterogeneous and often low quality.

ReliabilityCaveats4 of 4 checks completeRead the 2 entries ↓
Abstract

Abstract The serotonin hypothesis of depression is still influential. We aimed to synthesise and evaluate evidence on whether depression is associated with lowered serotonin concentration or activity in a systematic umbrella review of the principal relevant areas of research. PubMed, EMBASE and PsycINFO were searched using terms appropriate to each area of research, from their inception until December 2020. Systematic reviews, meta-analyses and large data-set analyses in the following areas were identified: serotonin and serotonin metabolite, 5-HIAA, concentrations in body fluids; serotonin 5-HT 1A receptor binding; serotonin transporter (SERT) levels measured by imaging or at post-mortem; tryptophan depletion studies; SERT gene associations and SERT gene-environment interactions. Studies of depression associated with physical conditions and specific subtypes of depression (e.g. bipolar depression) were excluded. Two independent reviewers extracted the data and assessed the quality of included studies using the AMSTAR-2, an adapted AMSTAR-2, or the STREGA for a large genetic study. The certainty of study results was assessed using a modified version of the GRADE. We did not synthesise results of individual meta-analyses because they included overlapping studies. The review was registered with PROSPERO (CRD42020207203). 17 studies were included: 12 systematic reviews and meta-analyses, 1 collaborative meta-analysis, 1 meta-analysis of large cohort studies, 1 systematic review and narrative synthesis, 1 genetic association study and 1 umbrella review. Quality of reviews was variable with some genetic studies of high quality. Two meta-analyses of overlapping studies examining the serotonin metabolite, 5-HIAA, showed no association with depression (largest n = 1002). One meta-analysis of cohort studies of plasma serotonin showed no relationship with depression, and evidence that lowered serotonin concentration was associated with antidepressant use ( n = 1869). Two meta-analyses of overlapping studies examining the 5-HT 1A receptor (largest n = 561), and three meta-analyses of overlapping studies examining SERT binding (largest n = 1845) showed weak and inconsistent evidence of reduced binding in some areas, which would be consistent with increased synaptic availability of serotonin in people with depression, if this was the original, causal abnormaly. However, effects of prior antidepressant use were not reliably excluded. One meta-analysis of tryptophan depletion studies found no effect in most healthy volunteers ( n = 566), but weak evidence of an effect in those with a family history of depression ( n = 75). Another systematic review ( n = 342) and a sample of ten subsequent studies ( n = 407) found no effect in volunteers. No systematic review of tryptophan depletion studies has been performed since 2007. The two largest and highest quality studies of the SERT gene, one genetic association study ( n = 115,257) and one collaborative meta-analysis ( n = 43,165), revealed no evidence of an association with depression, or of an interaction between genotype, stress and depression. The main areas of serotonin research provide no consistent evidence of there being an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations. Some evidence was consistent with the possibility that long-term antidepressant use reduces serotonin concentration.

Key Claims

Primary finding · Supported

The main areas of serotonin research provide no consistent evidence of there being an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations.

certainty-graded findings broadly converge, but several non-genetic domains remain small, confounded, or very low certainty

Abstract; Discussion, p. 3253
Quote verified
Secondary · Well-supported

The two largest and highest quality studies of the SERT gene, one genetic association study and one collaborative meta-analysis, revealed no evidence of an association with depression, or of an interaction between genotype, stress and depression.

two high-certainty, very large analyses consistently report null gene and gene-stress results

Abstract; Results, p. 3252
Quote verified
Secondary · Tentative

Some evidence was consistent with the possibility that long-term antidepressant use reduces serotonin concentration.

the inference rests primarily on one cohort sensitivity analysis and indirect supporting evidence

Abstract; Discussion, pp. 3253–3254
Quote verified
Secondary · Tentative

Two meta-analyses of overlapping studies examining the 5-HT1A receptor, and three meta-analyses of overlapping studies examining SERT binding showed weak and inconsistent evidence of reduced binding in some areas.

overlapping, medication-confounded imaging studies provide inconsistent and very-low-certainty evidence

Abstract; Results, pp. 3251–3252

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Six domains synthesised in one framework

The paper brings biochemical, receptor, transporter, depletion, genetic, and gene-environment evidence into one umbrella synthesis and distinguishes high-certainty null findings from very-low-certainty signals.

↳ Methods, six research areas; Table 3; Results, Overall results

#methodological rigour

Certainty ratings shape the conclusions

AMSTAR-2, adapted AMSTAR-2, and STREGA assessments feed into modified GRADE ratings that are reflected in the overall results and discussion rather than reported as a detached checklist.

↳ Methods, Data analysis; Table 3; Results, Overall results

#methodological rigour

Overlapping evidence is not double-counted

The review does not combine overlapping meta-analyses, thereby avoiding duplicate weighting of primary studies, and it explicitly explains this decision.

↳ Abstract; Methods, Data analysis

Limitations

#methodological rigour

Initial screening lacked independent duplication

Each team member searched and screened assigned domains, with full-team discussion only when uncertainty arose. This is not independent dual screening and increases the risk of missed eligible evidence.

↳ Methods, Data analysis

#methodological rigour

Recency rule may shape inclusion

The review includes only the five most recent studies when more than five are available, excluding eleven otherwise eligible reports. The effect of this rule on domain-level conclusions is not fully tested.

↳ Methods, inclusion criterion 5; Figure 1

#positioning

Underlying evidence is often fragile

Most included reviews satisfied fewer than half of the appraisal criteria, and many non-genetic studies were small or unable to exclude prior antidepressant effects. These limitations constrain the certainty of several domains underlying the headline synthesis.

↳ Results, Search results and quality rating; Table 3; Discussion, limitations paragraphs

Does this match your read? Add your assessment ↓

Nabu Commentary

The central synthesis is supported most strongly by large genetic studies and moderate-certainty serotonin and 5-HIAA findings, while receptor, transporter, and depletion evidence is explicitly treated as lower certainty. Table 3 carries appraisal results into domain-level conclusions, and the decision not to pool overlapping meta-analyses avoids double-counting. The main methodological deduction arises from the Methods statement that individual team members screened assigned domains rather than using independent dual screening. Additional discretion comes from the five-most-recent inclusion rule and the modified GRADE algorithm, although neither was shown to overturn the principal interpretation.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.8±0.1

Contribution
4.0

The review unifies six previously dispersed research domains and presents a meaningful synthesis of whether lower serotonin activity is associated with depression. Its central conclusion is evidence-bounded, although certainty varies substantially across domains.

Introduction, final paragraph; Results, Overall results; Discussion, opening paragraph

“The main areas of serotonin research provide no consistent evidence”

Methodological Rigour
3.5

The registered, multi-database review uses dual extraction, study-type-specific appraisal, explicit certainty grading, and a justified decision not to pool overlapping reviews. Initial eligibility screening was performed by one allocated team member per domain, while the five-most-recent rule and bespoke GRADE modification add methodological discretion.

Methods, Search strategy and selection criteria; Methods, Data analysis; Table 3

“Each member of the team was allocated one to three domains”

Reporting
4.0

The paper proceeds coherently from six defined questions through domain-specific results to a certainty-calibrated conclusion. Technical density and the causal wording surrounding absence of support require careful reading but do not materially misrepresent the findings.

Abstract; Methods, six research areas; Results, Overall results; Discussion, opening paragraph

“no convincing evidence that depression is associated with, or caused by, lower serotonin concentrations or activity”

Positioning
4.0

Supportive, critical, and conflicting findings are discussed, including earlier positive genetic studies and medication-confounded imaging results. Limitations are carried into interpretation, although the possible bias from restricting prolific domains to the five most recent studies is not deeply examined.

Introduction; Methods, inclusion criterion 5; Results, SERT gene and gene-stress interactions; Discussion, limitations paragraphs

“the findings of this umbrella review are dependent on the quality of the included studies”

Lower confidence on Methodological Rigour, Positioning — domain match limited.

Reliability

Caveats4 of 4 checks


Internal CoherenceNoted

The paper is internally coherent overall and transparently documents source-data discrepancies and its selective table-display rule. These presentation and reconstruction choices warrant attention but do not contradict the central interpretation.

Research ConductNoted

The protocol registration, subsequent update, data-availability statement, and relevant interests are disclosed. The antidepressant-discontinuation-related roles create interpretive context but no evidence of concealment or threshold-level conduct failure.

Flags: 3 declared / 5 total

Reference IntegrityClean

69 of 69 checkable references verified

75 references in manuscript 6 have no canonical index record — counted, but not index-checkable 2 references confirmed by manual review

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Mental health · Depressive disorders
Type of advanceSynthesis
Route to useSuggested
AdvanceAdvances
BeneficiariesLarge
CitationsFWCI 49.1
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessValidated
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The primary claim rests on high-certainty evidence from large independent genetic studies and multiple meta-analyses across research areas, synthesising real-world human data from many cohorts and datasets.

From the paper
“The idea that depression is the result of a chemical imbalance also influences decisions about whether to take or continue antidepressant medication and may discourage people from discontinuing treatment, potentially leading to lifelong dependence on these drugs.”

The paper implies its findings should inform how clinicians and patients understand depression causation and antidepressant decisions, but names no specific actor or decision procedure.

Pathway

Clinicians, guideline bodies and patient-education materials would use these findings to revise how depression's causes are explained and inform antidepressant prescribing and discontinuation discussions.

Barrier

Entrenched professional and public belief in the chemical-imbalance model, plus the indirectness of evidence on antidepressant effects, may slow uptake in clinical communication and prescribing practice.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline

    Montagne, Nation, Sagare, et al. · 2020 · Clinical medicine

    Primary claim

    Our findings suggest that breakdown of the BBB contributes to APOE4-associated cognitive decline independently of Alzheimer's disease pathology, and might be a therapeutic target in APOE4 carriers.

    Tentative
    Evidence Score
    2.7±0.2
    Reliability
    Caveats
  2. Playing With Fear: A Field Study in Recreational Horror

    Marc Malmdorf Andersen, Uffe Schjoedt, Henry C. W. Price, et al. · 2020 · Psychology

    Primary claim

    Our results show that enjoyment has an inverted-U-shaped relationship with fear across repeated self-reported measures.

    Tentative
    Evidence Score
    3.2±0.2
    Reliability
    Caveats
  3. Wake-active brainstem GABA neurons signal sleep pressure by upregulating AMPA receptors to drive recovery sleep

    2026 · Basic medicine

    Primary claim

    Following SD, PnO Vgat cells transiently switched for the first hour to higher activity during non-REMS (NREMS), promoting RS.

    Supported
    Evidence Score
    3.8±0.1
    Reliability
    Caveats

How the rubric works →